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Abstract
Objective: The primary aim of this study was to determine age-stratified rates of co-existing bacterial meningitis in children
with urinary tract infection (UTI). The secondary aims of this study were to determine the causative pathogens of UTI, and
the clinical features and outcome of children with co-existing meningitis.
Methods: Analysis of data collected over a nine-year period at a tertiary pediatric hospital in Australia. Study population:
children below 16 years of age with culture-confirmed UTI and a paired CSF sample.
Results: A total of 748 episodes in 735 cases were included in the final analysis. The commonest pathogens causing UTI
were Escherichia coli (67.4%), Enterococcus faecalis (8.4%), Klebsiella oxytoca (3.5%) and Klebsiella pneumoniae (3.5%). Only
two (1.2%; 95% CI: 0.15–4.36%) of 163 neonates (between 0 and 28 days of age) with UTI had co-existing meningitis. Both
presented with pyrexia, irritability and lethargy, and recovered uneventfully with antibiotic treatment. There were no cases
of co-existing meningitis among 499 infants (between 29 days and 12 months of age) with UTI (95% CI: 0.00–0.74%), or any
of the 86 children aged 12 months or over (95% CI: 0.00–4.20%).
Conclusions: These findings indicate that clinicians should have a low threshold to perform a lumbar puncture in neonates
with UTI, as the risk of co-existing meningitis is not insignificant in this age group. In contrast, beyond the neonatal period,
the risk is small and a more selective approach is warranted.
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Introduction
Urinary tract infection (UTI) is common in infants and young
children. Between 1% and 15% of young children presenting to
hospital with pyrexia have an underlying UTI [1,2]. Previous
studies show that bacteremia in association with UTI is not
uncommon in infants, occurring in 4% to 10% [3–7]. As
meningitis is generally the result of dissemination of bacteria via
the bloodstream and subsequent penetration of the blood-brain
barrier [8,9], it has been suggested that young children with UTI
are therefore at higher risk of co-existing meningitis.
A study by Bergstrom et al. published in 1972, which is
frequently referred to in this context, suggests that co-existing
meningitis is very common in infants with UTI [10]. The authors
reported that co-existing bacterial meningitis was present in six
(19.4%) of the 31 infants with UTI who had a lumbar puncture.
Subsequent studies have reported considerably lower estimates for
the risk of co-existing meningitis in children presenting with UTI
[3–7,11–19]. However, the majority of studies have significant
limitations, including small sample size [4,6,13,15–19] and
absence of a precise definition for UTI [12,17]. Furthermore, in
the majority of previous studies, the study population exclusively
comprised infants younger than three months of age, [3–6,12,14–
18] and therefore only limited data exist regarding older infants, as
well as children outside infancy.
Accurately determining the rate of co-existing meningitis in
children with UTI is clinically highly relevant. In the absence of
reliable data, it remains uncertain whether young children with
UTI should always have a lumbar puncture to rule out co-existing
meningitis [20]. The age after which the risk of co-existing
meningitis becomes negligible is also unknown. Identification of
co-existing meningitis is critically important, as failure to diagnose
central nervous system (CNS) infection may result in partial or
incomplete treatment, particularly in view of the fact that several
national guidelines suggest that uncomplicated UTI in children
can be treated with short courses of oral antibiotics, some of which
have poor CNS penetration [21,22].
The primary aim of our study was to determine accurate, age-
stratified rates of co-existing meningitis in children with culture-
proven UTI. Secondarily the study aimed to determine the
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clinical features and outcome of children with co-existing
meningitis.
Methods
Study design and setting
The study was conducted at the Royal Children’s Hospital
Melbourne, the largest pediatric referral center in the state of
Victoria, Australia (estimated population 1.19 million children
between 0 and 18 years of age). We analyzed data collected over a
nine-year period (1
st Jan 2001 to 1
st Jan 2010). The following data
were extracted from the hospital microbiology department database:
patient age, date and type of sample, and bacterial culture results. In
patients who potentially fulfilled the case definition of UTI and co-
existing meningitis, additional clinical and laboratory data were
extracted from the patient’s record by one of the investigators.
Inclusion criteria and definitions
Patients between one day and 16 years of age were eligible for
inclusion if they had a positive urine culture and a cerebrospinal
fluid (CSF) sample obtained within 48 hours of the urine sample
being collected. Cases were identified by matching all children
with a positive urine culture result during the study period with
CSF culture results.
In this study, ‘neonate’ was defined as a patient between 0 and
28 days of age; ‘infant’ was defined as a patient between 29 days
and 12 months of age. UTI was defined as: i) a pure growth of a
single bacterial pathogen with $10
2 colony forming units (CFU)/
ml from a urine sample obtained by suprapubic aspirate or
catheterization, ii) $10
3 CFU/ml from a clean catch urine sample
or, iii) $10
5 CFU/ml from a bag urine sample. In cases with more
than one UTI, these were included in the analysis as separate
episodes if they occurred more than 14 days apart. For each
episode, only the result of the first positive urine culture was
included in the data analysis. In the event that two different
bacterial pathogens were isolated from two separate urine samples
during one episode, the culture result of the more reliable sample
was included in the final analysis (suprapubic aspirate.catheter
urine.clean catch urine.bag urine).
CSF pleocytosis was defined as a CSF white blood cell (WBC)
count on microscopy of .19/ml during the first month of life, and
.9/ml thereafter, based on recently published data [23]. In blood-
stained CSF samples, the WBC count was corrected according to
the number of red blood cells using a fixed ratio of 1:500 [24].
Definite meningitis was defined as the growth of a single bacterial
pathogen from a CSF sample. Co-existing meningitis was defined
as a positive CSF culture with a pure growth of the same bacterial
pathogen that was isolated from the patient’s urine culture.
Micrococcus species, Bacillus species, coagulase-negative staphylo-
cocci and viridans streptococci isolated from CSF were considered
to be contaminants [25], unless the same organism was
simultaneously isolated from urine.
Exclusion criteria
Episodes with urine cultures that showed mixed growth (ie two
or more organisms in one sample) were excluded, as these are
likely to represent contaminated samples. Episodes with urine
samples growing fungal organisms (ie possible fungal UTI) were
also excluded.
Assays for antimicrobial activity
CSF samples were routinely tested for antimicrobial activity to
identify samples which may yield false-negative culture results due
to the presence of antibiotics administered prior to the CSF being
obtained, as previously described with minor modifications [26].
Briefly, the antimicrobial activity assays were done by adding one
drop of CSF to Mueller-Hinton agar plates (Oxoid, Adelaide,
Australia) enriched with a fully sensitive strain (ATCC 6633) of
Bacillus subtilis (Chrisope Technologies, Louisiana, USA). Presence
of antibiotics leads to inhibition of bacterial growth resulting in a
zone of clearing around the inoculated CSF, which is assessed after
overnight incubation at 35uC.
Data analysis
Data analysis and the construction of the figures were done
using Prism (GraphPad Software Inc., La Jolla, California) and
Excel (Microsoft, Redmond, Washington). Nonparametric statis-
tics were used for age-related data, as these data were not normally
distributed. The ‘exact’ method was used to calculate 95%
confidence intervals (CI). A two-sided chi-square test was used to
compare the rate of co-existing meningitis between different age
groups.
Ethical approval
The study was approved by the Human Research Ethics
Committee of the Royal Children’s Hospital Melbourne (HREC
30062A).
Results
A total of 735 cases who fulfilled the inclusion criteria were
identified. Thirteen of these cases had two episodes of UTI during
which CSF had been obtained. None of the cases had three or
more episodes. Therefore, a total of 748 episodes were included in
the final analysis. Table 1 shows the demographic characteristics
of the study population. The majority of cases (88.5%) were below
the age of 12 months.
In 607 (81.1%) episodes, urine and CSF samples had been
obtained on the same day, in 114 (15.2%) episodes within one day,
and in 27 (3.6%) episodes within two days. The most common
type of urine sample was catheter urine (31.1%), followed by clean
catch urine (28.2%), and suprapubic aspirates (20.9%) (Table 2).
The spectrum and frequency of bacterial pathogens isolated
from urine cultures are summarized in Table 2. Escherichia coli was
by far the commonest isolate, accounting for 67.4% of positive
urine cultures, followed by Enterococcus faecalis (8.4%), Klebsiella
oxytoca (3.5%) and Klebsiella pneumoniae (3.5%).
Cases with UTI and definite co-existing meningitis
There were two cases of UTI with definite co-existing bacterial
meningitis. Case 1 was a male neonate who had been diagnosed
with bilateral renal dysplasia antenatally. On day 15 of life he
presented with pyrexia, poor feeding, irritability and lethargy. The
serum C-reactive protein (CRP) concentration was elevated
(36 mg/L); the peripheral blood WBC was within normal limits.
A catheter urine sample was obtained and a lumbar puncture was
done at the same time. A pure growth of Staphylococcus aureus was
detected in both the urine and the CSF sample. The patient
received two weeks of intravenous flucloxacillin and gentamicin.
Case 2 was a 19-day-old male neonate who presented with
pyrexia, poor feeding, irritability and lethargy. A catheter urine
sample was obtained and a lumbar puncture done 12 hours later.
The CRP was within normal range (,8 mg/L), but the full blood
count revealed neutrophilia (total WBC 12.0610
9/L, neutrophils
9.0610
9/L). A pure growth of E. coli was detected in both the
urine and the CSF sample; an assay for E. coli K1 antigen in CSF
was also positive. The patient received two weeks of ceftriaxone
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monotherapy. Both patients had an uncomplicated clinical course,
and were discharged without evidence of neurological sequelae.
Table 1 shows the rate of definite co-existing meningitis
according to age group. The overall rate of definite co-existing
meningitis in infants under the age of 12 months was 0.30% (95%
CI: 0.04–1.09%); for all ages combined the incidence was 0.27%
(95% CI: 0.03–0.96%). There were no cases of definite co-existing
meningitis among the 499 infants with UTI that presented outside
the neonatal period (95% CI: 0.00–0.74%). Further analysis
confirmed that the rate of definite co-existing meningitis was
significantly higher in neonates than in infants outside the neonatal
period (p=0.013).
Description of additional cases with positive CSF cultures
In an additional four patients, pathogenic bacteria were isolated
from the CSF sample, but these did not fulfill the case definition
for definite co-existing meningitis.
In two cases, it is likely that the children did not have meningitis.
In an 8-day-old, previously healthy term neonate, Enterococcus
faecalis was isolated from urine obtained by suprapubic aspirate.
The CSF sample did not show pleocytosis (CSF analysis: WBC
10/ml (neutrophils 0; lymphocytes 10), RBC 18,750/ml, protein
1.18 g/L, glucose 2.6 mmol/L) and no antimicrobial activity was
detected. Micrococcus species were grown from CSF within
48 hours. The following day, a scanty growth of E. faecalis was
detected in CSF enrichment cultures. In a 40-day-old infant with
congenital posterior urethral valves, a urine sample obtained by
suprapubic aspirate grew E. coli; the CSF grew scanty mixed E. coli
and E. faecalis (CSF analysis: WBC 8/ml (neutrophils 6;
lymphocytes 2), RBC 6,410/ml, protein 0.42 g/L, glucose
2.5 mmol/L). In both cases CSF findings were not suggestive of
meningitis making contamination of the CSF sample likely.
In the other two cases the children had bacterial meningitis, but
their urine sample was likely contaminated. In a two-month-old
infant with Down’s syndrome and complex cardiac malformation,
a catheter urine sample grew E. coli, while group B streptococci
were isolated from blood cultures and the CSF. In a 16-month-old
child with a ventriculo-peritoneal shunt, E. coli was isolated from a
urine sample (sampling method not stated on the request form),
while CSF cultures grew S. aureus.
Antimicrobial activity assay results
Antimicrobial activity assays were done on the CSF samples
from 730 (97.6%) episodes (Figure 1). In 658 (90.1%) of these CSF










Number of cases with co-existing
meningitis
(n=2)
,1 month 163 (21.8%) 2 (1.2%; 95% CI: 0.15–4.36%)
1–2 months 304 (40.6%) 0 (95% CI: 0.00–1.25%)
3–5 months 129 (17.2%) 0 (95% CI: 0.00–2.82%)
6–11 months 66 (8.8%) 0 (95% CI: 0.00–5.44%)
12–23 months 32 (4.3%) 0 (95% CI: 0.00–10.89%)
24–59 months 21 (2.8%) 0 (95% CI: 0.00–16.11%)
$5 years 33 (4.4%) 0 (95% CI: 0.00–10.58%)
CI: confidence interval; IQR: interquartile range.
doi:10.1371/journal.pone.0026576.t001
Table 2. Urine sampling technique and urine culture isolates.
Type of urine sample
(n=748)
Suprapubic aspirate 156 (20.9%)
Catheter 233 (31.1%)
Clean catch 211 (28.2%)
Urine bag 7 (0.9%)
Nephrostomy/ureterostomy 6 (0.8%)
Not stated 135 (18.0%)
Pathogen isolated in urine culture
(n=748)
Escherichia coli 504 (67.4%)
Enterobacter faecalis 63 (8.4%)
Klebsiella oxytoca 26 (3.5%)
Klebsiella pneumoniae 26 (3.5%)
Enterobacter cloacae 19 (2.5%)
Proteus mirabilis 18 (2.4%)
Group B streptococci 17 (2.3%)
Pseudomonas aeruginosa 13 (1.7%)
Staphylococcus aureus 12 (1.6%)
Citrobacter species 9 (1.2%)
Serratia marcescens 5 (0.7%)
Other 36 (4.8%)
doi:10.1371/journal.pone.0026576.t002
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remaining CSF samples, antimicrobial activity was detected. Four
of these samples were clotted and could not be analyzed by
microscopy. Of the remaining 68 samples, only 10 had a corrected
WBC count consistent with pleocytosis (Table 3). One of these
patients was case 2 described above. In five patients, an alternative
diagnosis explaining the CSF pleocytosis was identified, compris-
ing meningococcal sepsis/meningitis, ventriculo-peritoneal shunt
infection, CNS lymphoma, miliary tuberculosis and cytomegalo-
virus infection. In none of the remaining four patients were
microscopy and biochemical findings characteristic of bacterial
meningitis.
Discussion
To our knowledge this study is the first to provide age-stratified
data on co-existing meningitis in children of all ages with UTI.
Our study is considerably larger than any previous study in this
area with the exception of the recent study by Schnadover et al.
that exclusively investigated patients between 29 and 60 days of
age [3].
The aforementioned study by Bergstrom et al. is frequently
quoted as evidence that young children with UTI are at significant
risk of co-existing meningitis [10]. However, the limitations of this
study have previously been highlighted, and it is likely that it
considerably overestimates the risk of co-existing meningitis [6,14].
Firstly, all urine samples in this study were obtained using urine
bags, which are far more prone to contamination than samples
obtained by sterile techniques (ie suprapubic aspiration or
catheterization) [27]. This may have led to a considerable number
of false-positive urine culture results. Consequently, a significant
proportion of patients with meningitis could falsely have been
classified as having co-existing UTI. Secondly, only 31 (38.8%) of
the 80 neonates with UTI in this study had a lumbar puncture. As
it is likely that lumbar punctures were predominantly performed
on the ‘sicker’-appearing neonates, this could have introduced a
significant selection bias and skewed the reported rate of co-
existing meningitis even further.
Since the publication by Bergstrom et al., several other studies
have investigated co-existing meningitis in children with UTI
[3,7,11–19]. However, the majority are limited by the size of the
study population, which in most instances comprised fewer than
200 patients with UTI who had a lumbar puncture [4,14,17,19],
or even less than 100 patients [6,13,15,16,18]. This is a significant
limitation, in the light of more recent data suggesting that co-
existing meningitis is uncommon in patients with UTI.
The majority of previous studies have exclusively focused on
infants under three months of age [3–6,10,12,14–18], and the
available data in older children are limited. In previous reports,
the rates of co-existing meningitis in children with UTI varied
between 0% [6,12–15,17,19] and 2% [18]. However, a further
limitation of previous studies is that only few have reported
Figure 1. Summary of antimicrobial activity assays done on cerebrospinal fluid samples. Summary of the results of the antimicrobial
activity assays (AAA) in relation to cerebrospinal fluid (CSF) microscopy results.
doi:10.1371/journal.pone.0026576.g001
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interpretation of incidence data related to uncommon events. Our
data show that the risk of co-existing meningitis in infants with
UTI below the age of one month is not insignificant, with the true
risk being between 0.15% and 4.36%. In contrast, in infants
outside the neonatal age this risk is relatively small (between 0.00%
and 0.74%).
Ginsburg and McCracken, who reported a study in 100 infants
with UTI, found that the proportion of positive blood cultures
correlated inversely with age [13]. Positive blood cultures were
observed in 31.4% of cases aged below 1 month, in 18.4% of cases
aged 1 to 3months,and in only 5.6% ofcasesaged 3 to 12months.In
view of the fact that co-existing bacterial meningitis in patients with
UTI is generally the result of bacterial dissemination via the blood
stream,thisobservationfurthersupportsthenotionthattheriskofco-
existing meningitis declines significantly with increasing age.
While it could be argued that universal lumbar puncture would
be the safest strategy in infants with UTI, this procedure is
uncomfortable and can be associated with rare, but potentially
serious complications, such as brainstem herniation, introduction
of infectious organisms into the CSF and epidermoid tumors [28–
30]. Based on our data, in conjunction with the results from other
studies, we do not believe that universal lumbar puncture in
children with UTI outside the neonatal age is necessary. This does
not imply that lumbar puncture is not warranted in patients
outside the neonatal period who have symptoms or signs
indicating possible meningitis.
In our study, both patients with co-existing meningitis were
neonates who presented with features suggestive of meningitis,
including pyrexia, poor feeding, irritability and lethargy. However,
clinical features are insufficiently sensitive to reliably rule out
meningitis in neonates and typical meningeal signs are often
absent in this age group [9,31].
It is important to highlight that our study only includes data
from patients who had paired urine and CSF results. Patients with
UTI who did not have a lumbar puncture were not included, as
the presence or absence of meningitis cannot be established.
Consequently, our data are more likely to overestimate rather than
underestimate the risk of co-existing meningitis, as clinicians are
likely to have done a lumbar puncture preferentially on ‘sicker’-
appearing children.
The spectrum and frequency of bacterial pathogens causing
UTI in our study is consistent with previous pediatric studies, with
E. coli accounting for more than two thirds of infections [3–
6,13,14,16,18,32,33]. Similar to other reports Enterococcus, Klebsiella
and Enterobacter species were also commonly implicated [3,5–
7,14,16,18].
Strengths and limitations
The strengths of our study include the large sample size, the
age-stratification of data and the quality of the urine samples
included. More than half of the urine samples were obtained by
suprapubic aspirate or catheterization, which are less prone to
contamination than other sampling methods [27]. Only a small
proportion were documented to be bag urine samples. In addition,
we excluded all urine samples with mixed growth to prevent the
inclusion of patients with false-positive urine culture results.
Limitations of our study include its retrospective nature. We
cannot exclude with absolute certainty the possibility that some
patients had received antibiotics prior to the CSF sample being
obtained, thereby potentially rendering their CSF culture false-
negative, as we did not have data regarding the timing of the
lumbar puncture and the initiation of antibiotic treatment.
However, in the large majority (81.1%) of episodes CSF cultures
were obtained on the same day as the urine sample. Also,
antimicrobial activity was detected in the CSF in only 9.9% of the
episodes. The vast majority of these patients had a normal CSF
WBC count, while only ten had CSF pleocytosis. In only four of
these could no alternative diagnosis be established; in none of these
patients were microscopy and biochemical findings characteristic
of bacterial meningitis. By assessing these aspects in detail we have
limited the number of potentially false-negative CSF culture
results, which adds to the robustness of our data. Notably, only one
previous study, which included only 106 patients, has attempted to
identify patients who had received antibiotics prior to lumbar
puncture [19].
Conclusions
Identification of co-existing meningitis in children presenting
with UTI is critically important, as failure to detect CNS infection
can result in partial treatment of meningitis with potentially severe
long-term consequences [8,9,31]. Our findings suggest that the risk
















A 9.5 7690 7290 400 60 1.49 2.8 Meningococcal sepsis (blood culture: N. meningitidis;C S F
microscopy: Gram-negative diplococci)
B 0.7 1820 1590 230 700 1.62 4.2 Co-existing E. coli UTI and meningitis
(‘Case 2’ described in results section)
C 2.4 1674 1557 117 36 1.00 2.6 VP shunt infection (CSF microscopy: Gram-positive cocci;
urine culture: K. pneumoniae)
D 184.3 620 0 620 30 2.87 ,1.2 CNS lymphoma
E 2.7 447 183 264 1760 0.14 2.7
F 27.2 144 83 61 24 n.d. n.d. Miliary tuberculosis
G 63.5 92 15 77 68 1.66 3.2
H 4.1 19 2 17 4250 0.42 3.1
I 10.6 16 0 16 0 1.04 3.0 Cytomegalovirus Infection
J 1.1 12 2 10 16 0.88 2.8
CNS: central nervous system; CSF: cerebrospinal fluid; n.d.: not done; RBC: red blood cell count; VP: ventriculo-peritoneal; WBC *: white blood cell count (uncorrected).
doi:10.1371/journal.pone.0026576.t003
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month is not insignificant. In contrast, outside the neonatal period
this risk is small, indicating that a selective, rather than universal,
approach to lumbar puncture is warranted.
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